Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves new ‘full range of vision’ IOL
➤ Imaging platform designed for patients in supine position receives FDA clearance
➤ Last patient dosed in Phase 3 study of non-IV, non-opioid sedation method
➤ Phase 2 study begins to assess neuropathic corneal pain treatment
➤ Plans to submit BLA for treatment of severe vision loss due to retinitis pigmentosa
➤ Research discovers protein related to AMD
➤ ASCRS news and events
➤ Last patient visit in proof-of-concept cell therapy
➤ Phase 2 data for allergic eye inflammation drop published
➤ NDA resubmission to the FDA for topical ocular reproxalap
➤ Positive topline results from Phase 2b suprachoroidal wet AMD therapy
➤ Complimentary access to video journal
➤ Partnership news
➤ ASCRS news and events
➤ Roll-out expanded for presbyopia-correcting IOL
➤ Study: Phase 3 clinical trials evaluate phentolamine ophthalmic solution
➤ AI listening innovation for ophthalmologists
➤ ASCRS news and events
➤ Research: quest for cataract reversal continues
➤ First allogenic cell therapy for treating corneal endothelial disease
➤ Enrollment complete in Phase 2b geographic atrophy treatment study
➤ European agency maintains negative opinion for intravitreal pegcetacoplan for geographic atrophy
➤ Companies partner to further development of new glaucoma drug
➤ ASCRS news and events
➤ FDA approves robotic OCT color fundus camera with OCTA
➤ Company to begin Phase 3 trial for Stargardt macular degeneration treatment
➤ 24-month results of oral treatment for geographic atrophy
➤ Positive Phase 2 results for investigational choroidal melanoma treatment
➤ Partnership news
➤ ASCRS news and events
➤ Whole-eye transplant 1 year later
➤ Phase 3 trial investigating new presbyopia drop therapy begins
➤ Study reports on multi-interventional glaucoma technique
➤ Topline results from Phase 3 trial for drug for active thyroid eye disease
➤ Pilot study complete for AMD treatment
➤ ASCRS news and events
➤ ASCRS mourns death of I. Howard Fine, MD
➤ New non-diffractive monofocal and toric IOLs
➤ 36-month results from clinical trials for new glaucoma device
➤ FDA grants IND to stem cell therapy intended to treat photoreceptor diseases
➤ Company launches ophthalmology-specific contract research organization
➤ ASCRS news and events
➤ Study: ocular manifestations of Mpox
➤ ‘World’s first’ spiral IOL designed with artificial intelligence
➤ First-in-human implantation of wireless IOP sensor
➤ Final patient visit for Phase 2 wet AMD treatment trial
➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy
➤ ASCRS news and events
➤ Rare Pediatric Disease designations granted for gene therapies
➤ Tentative FDA approval granted to generic drop for eye redness
➤ Acquisition news
➤ ASCRS news and events
➤ NDA submitted for presbyopia treatment
➤ FDA approves AMD treatment
➤ Primary endpoint achieved in Phase 3 trial of reproxalap for dry eye
➤ Clinical trial results that supported new excimer laser approval published
➤ Company updates on several clinical trials
➤ First patient dosed in Phase 2 trial for intravitreal steroid implant for DME treatment
➤ ASCRS news and events
